galantamine has been researched along with kynurenine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albuquerque, EX; Bruno, JP; Pellicciari, R; Pereira, EF; Schwarcz, R; Wu, HQ | 1 |
| Alexander, KS; Bruno, JP; Schwarcz, R; Wu, HQ | 1 |
| Alexander, KS; Bruno, JP; Pershing, ML; Pocivavsek, A; Schwarcz, R; Wu, HQ | 1 |
| Darlington, LG; Forrest, CM; Khalil, OS; McNair, K; Pisar, M; Stone, TW | 1 |
| Aaronson, ST; Davis, W; Koola, MM; Kozak, R; Meissen, JK; Nikiforuk, A; Sawant-Basak, A; Sklar, J | 1 |
1 trial(s) available for galantamine and kynurenine
| Article | Year |
|---|---|
Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
Topics: Adolescent; Adult; Cognitive Dysfunction; Drug Therapy, Combination; Female; Galantamine; Humans; Kynurenine; Male; Memantine; Middle Aged; Neuropsychological Tests; Nootropic Agents; Retrospective Studies; Schizophrenia; Signal Transduction; Young Adult | 2018 |
4 other study(ies) available for galantamine and kynurenine
| Article | Year |
|---|---|
The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Astrocytes; Cholinesterase Inhibitors; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Extracellular Fluid; Galantamine; Glutamic Acid; Kynurenic Acid; Kynurenine; Male; Microdialysis; Nicotinic Antagonists; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Schizophrenia | 2010 |
Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Brain; Cognition; Cognition Disorders; Disease Models, Animal; Galantamine; Glutamic Acid; Kynurenic Acid; Kynurenine; Male; Nootropic Agents; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Nicotinic; Schizophrenia | 2012 |
Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
Topics: Animals; Attention; Brain; Cognition; Female; Galantamine; Glutamic Acid; Kynurenic Acid; Kynurenine; Male; Nootropic Agents; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Set, Psychology | 2013 |
Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine.
Topics: Adjuvants, Pharmaceutic; Animals; Doublecortin Domain Proteins; Doublecortin Protein; Female; Galantamine; Gene Expression Regulation; Gestational Age; Hippocampus; In Vitro Techniques; Kynurenine; Kynurenine 3-Monooxygenase; Long-Term Potentiation; Male; Mice; Mice, Knockout; Microtubule-Associated Proteins; Neuronal Plasticity; Neuropeptides; Nootropic Agents; Pregnancy; Prenatal Exposure Delayed Effects; Probenecid; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Glutamate | 2015 |